PuraCap Caribe, the first Chinese investment pharmaceutical company on the Island that produces generic products in different presentations has expanded its operations in Puerto Rico, after pumping $7.3 million into its plant.
New Jersey-based PuraCap Pharmaceutical LLC recently announced the acquisition of Blu Pharmaceutical LLC and Blu Caribe Inc., creating PuraCap International LLC, a joint venture between PuraCap and Dangdai International Group Co., Ltd.